about
Opsoclonus-myoclonus syndrome and exaggerated startle response associated with small-cell lung cancer.Monosymptomatic clinically isolated syndrome with sudden sensorineural hearing loss: case report and critical review of the literature.Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.JC virus granule cell neuronopathy onset two months after chemotherapy for low-grade lymphomaSpinal cord normalization in multiple sclerosis.Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.Retinal damage and vision loss in African American multiple sclerosis patientsRelationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective studySafety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinningIn vivo identification of morphologic retinal abnormalities in neuromyelitis opticaDEFORMABLE REGISTRATION OF MACULAR OCT USING A-MODE SCAN SIMILARITY.Retinal layer segmentation of macular OCT images using boundary classification.In vivo demonstration of homonymous hemimacular loss of retinal ganglion cells due to a thalamic lesion using optical coherence tomography.Optical coherence tomography in x-linked adrenoleukodystrophy.Neurological picture. Nitrous oxide-induced myelopathy with inverted V-sign on spinal MRI.Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with optical coherence tomography.Characteristics of morphologic macular abnormalities in neuroimmunology practice.Comparison of point estimates and average thicknesses of retinal layers measured using manual optical coherence tomography segmentation for quantification of retinal neurodegeneration in multiple sclerosis.OCT is an alternative to MRI for monitoring MS - YES.Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal studySegmentation of retinal OCT images using a random forest classifierSafety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosisAuthor ResponseRetinal measurements predict 10-year disability in multiple sclerosisSafety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosisSpinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thicknessReporting of R2 Statistics for Mixed-Effects Regression ModelsEffect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosisDeepHarmony: A deep learning approach to contrast harmonization across scanner changesProgressive multiple sclerosis is associated with faster and specific retinal layer atrophyAssociation of body mass index with longitudinal rates of retinal atrophy in multiple sclerosisAlterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measuresAquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinningSafety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosisAuthor response
P50
Q30502659-055C22A4-2714-41B8-939B-E7C5B3B9CA3EQ30559792-FF057DBB-AD33-4D33-827F-0D6BAC9A2F2DQ33648360-94FD094F-FE39-4427-9FA2-D1803D2A7567Q33827403-D5A55903-B286-442B-A4AA-DF0620EE27BEQ34143450-7F99483B-3812-4D25-BF14-34E321054F1CQ34422726-199407B0-C9F0-4B5E-999C-484A0B95A1C7Q35044471-2AD81F79-04D9-4D7B-AB03-D286D7D4770DQ35106595-833E5B81-8B9A-4DA9-A430-DD40F5322DCCQ36496806-745884BC-2018-4232-AD2A-8D52BFBEAE72Q36645164-C80FC233-F66A-4AF8-AE63-EAEAC3910C3FQ36659432-2E4CDA9E-5B67-4516-86F3-F45BF9869FD7Q36869912-0FF71D29-2A1E-4144-BA14-4329F17C9049Q37482410-3CE5CC81-AFA0-48B2-BB4F-79E37A91A02EQ42933161-3D0ACA5D-BB05-4658-8045-0BB7B6646698Q43444085-5D82D3E5-2660-408E-B45F-7B6E7C501B8DQ45400343-F3BED027-187D-46CF-8D96-5328A2FF6205Q48148497-9A6BDD3C-A0A7-42CA-88A6-2E81A4C6F284Q48730697-EF929641-8537-4BA5-BC11-986E0E228ECEQ50072134-EECD9026-9A3A-4698-83E6-3D614289E220Q51326284-623A1EA5-5962-4519-AC98-EB3347678DB4Q54253716-93FC1B5E-5D76-4C6F-BE79-8C24F8C8A378Q57474921-0AB38090-D417-4B6F-B3BA-8735E4580727Q58030783-F99C4610-7512-407E-A164-D429C7D33A50Q60154177-D2E68A00-92A8-4CFA-8EB9-E6D68C452629Q64228792-75210079-B3F0-44B9-8085-D821EE34AD8FQ88008316-FC951269-83F9-43B1-92E2-45CB9EA4C55CQ90209281-F9203EE4-F055-4A42-BC7C-382F2209A802Q91328999-1B184BBB-59B4-4E6E-B063-D30AA89C3C35Q91446643-7ECB9A99-1D38-4098-ABD0-11DADCBAC5DBQ91846737-3AD68984-F8F7-4863-9D04-4C1BE444DD2FQ91883420-EFCF8079-2E3C-4472-B08D-70D63E65876BQ91983446-7DE2C7B3-55F6-4C6E-8099-F7B47994BE88Q92064296-6F22EB54-100E-44E2-B34B-65C513EB6A65Q92305627-072A8A37-D96F-48B9-900C-C713A3F09013Q95480822-C4DB1277-7C27-4A9D-91BC-014A31B1A34BQ95817327-BA4E6E2A-AC30-4E4C-A769-B2D4B1DFE044
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elias S Sotirchos
@ast
Elias S Sotirchos
@en
Elias S Sotirchos
@es
Elias S Sotirchos
@nl
type
label
Elias S Sotirchos
@ast
Elias S Sotirchos
@en
Elias S Sotirchos
@es
Elias S Sotirchos
@nl
prefLabel
Elias S Sotirchos
@ast
Elias S Sotirchos
@en
Elias S Sotirchos
@es
Elias S Sotirchos
@nl
P106
P1153
54879549800
P21
P31
P496
0000-0002-8812-1637